Videos

Catalent CEO Talks Gene Therapy Trends

A Q&A with John Chiminski

At BIO 2019 Contract Pharma had a chance to discuss gene therapy trends and Catalent’s recent acquisition of Paragon Bioservices with CEO John Chiminski.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters